Work

VEGF-A splicing variant in plasma is a predictive potential biomarker of bevacizumab in advanced non-squamous non-small cell lung cancer

Year: 2025

Type: article

Source: Journal of Chemotherapy

DOI: 10.1080/1120009x.2025.2605782

Authors: Akira Matsui, Masahiro Morise, Ryosuke Kikuchi, Fumie Kinoshita, Atsuo Suzuki, Ichidai Tanaka, Makoto Ishii, Shingo Matsumoto, Koichi Goto

Institutions: Nagoya University, Gifu University Hospital, Nagoya University Hospital, National Cancer Center Hospital East

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Award: A research focusing on establishing a minimally invasive method for predicting the efficacy of angiogenesis inhibition therapy in malignant respiratory tumors

OpenAlex ID: W7117354030

FWCI:

Cites: 25

Cited by:

Related to: